ALLOS THERAPEUTICS Aktie

1,28 EUR -1,4672%

Zu Ihrem Onlinebroker

kaufen verkaufen

ALLOS THERAPEUTICS Aktienkurs : 13.02. ( 15 Min. verzögert)
1,28 € Letzter Kurs	-1,47% Veränderung	1,30 € Vortag	1,30 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,30 - 1,28 Tag	2,49 - 0,945 52 Wochen	0 Tag	0 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

ALLOS THERAPEUTICS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

09.02.

Table of Unusual NASDAQ Stock Moves From RealTick

... 0.06 2.74 6 ALLOS THERAPEUTICS I ALTH 1.76 0.03 1.73 7 CAPITAL SOUTHWEST CO CSWC 91.10 0.08 0.09 8 RADIO ONE INC CL DN ROIAK...
07.02.

ALTH Seeks Review of Folotyn Verdict

Recently Allos Therapeutics Inc. (ALTH) submitted a request to the European Medicines Agency (EMA) seeking a review of the negative opinion issued by...

03.02.

Allos phase I combo study of Folotyn & Bexarotene demonstrate activity in ...

Allos Therapeutics Inc., a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, has released interim results from its ongoing phase I c…
30.01.

Allos Therapeutics requests re-examination of EMA opinion on Folotyn

Allos Therapeutics (NASDAQ:ALTH) said Monday it has asked the European Medicines Agency (EMA) to re-examine the negative opinion issued by an EMA committee for the company's Folotyn drug. Earlier…
29.01.

Equities Research Analysts' Ratings Reiterations for January, 29th (ALGN, ALNY ...

Allos Therapeutics Incorporated (NASDAQ: ALTH) had its “outperform” rating re-affirmed by analysts at Zacks Investment Research. They now have a $1.50 price target on the stock. Altera (NASDAQ: ALTR)…